middle.news
OncoSil’s PANCOSIL Trial Unveils Safer, Smarter Pancreatic Cancer Treatment
9:11am on Thursday 18th of September, 2025 AEST
•
Healthcare
Read Story
OncoSil’s PANCOSIL Trial Unveils Safer, Smarter Pancreatic Cancer Treatment
9:11am on Thursday 18th of September, 2025 AEST
Key Points
First CT-guided percutaneous OncoSil™ delivery for pancreatic cancer
90% technical success rate with manageable serious adverse events
Median overall survival of 20.6 months versus historical 13 months
Plans for expanded regulatory approvals in FY26
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
OSL
OPEN ARTICLE